BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
 | 
Apr 10, 2008
 |  BC Extra  |  Company News

FDA reviewing PML in CellCept & Myfortic patients

FDA said it is investigating a potential association between the use of CellCept mycophenolate mofetil and Myfortic mycophenolate and the development of progressive multifocal leukoencephalopathy (PML).

Roche (SWX:ROG) markets...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >